Dynamic modeling in ovarian cancer: An original approach linking early changes in modeled longitudinal CA-125 kinetics and survival to help decisions in early drug development-Reference-Cited by-同舟云学术

Dynamic modeling in ovarian cancer: An original approach linking early changes in modeled longitudinal CA-125 kinetics and survival to help decisions in early drug development

Published:2014-06 Issue:3 Volume:133 Page:460-466
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Wilbaux Mélanie,Hénin Emilie,Oza Amit,Colomban Olivier,Pujade-Lauraine Eric,Freyer Gilles,Tod Michel,You Benoit

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference30 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Can the pharmaceutical industry reduce attrition rates?;Kola;Nat Rev Drug Discov,2004

3. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1);Eisenhauer;Eur J Cancer,2009

4. Elucidation of relationship between tumor size and survival in non-small-cell lung cancer patients can aid early decision making in clinical drug development;Wang;Clin Pharmacol Ther,2009

5. Model-based prediction of phase III overall survival in colorectal cancer on the basis of phase II tumor dynamics;Claret;J Clin Oncol,2009

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of CA125 kinetics, half-life, and nadir in the treatment of epithelial ovarian cancer: a systematic review and meta-analysis;International Journal of Gynecologic Cancer;2023-11-10

2. Dynamic Prediction of Resectability for Patients with Advanced Ovarian Cancer Undergoing Neo-Adjuvant Chemotherapy: Application of Joint Model for Longitudinal CA-125 Levels;Cancers;2022-12-30

3. Comparative analysis of predictive values of the kinetics of 11 circulating miRNAs and of CA125 in ovarian cancer during first line treatment (a GINECO study);Gynecologic Oncology;2020-10

4. Validation of an online tool for early prediction of the failure-risk in gestational trophoblastic neoplasia patients treated with methotrexate;Cancer Chemotherapy and Pharmacology;2020-06-04

5. CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial;Clinical Cancer Research;2020-03-24